View : 652 Download: 0
VERY EARLY MOLECULAR RESPONSE (VEMR) WITH FRONTLINE DASATINIB TREATMENT IS A STRONG PREDICTOR OF LONG-TERM BCR-ABL1 TRANSCRIPT LEVELS IN CHRONIC MYELOID LEUKEMIA PATIENTS: PCR-DEPTH STUDY
- Title
- VERY EARLY MOLECULAR RESPONSE (VEMR) WITH FRONTLINE DASATINIB TREATMENT IS A STRONG PREDICTOR OF LONG-TERM BCR-ABL1 TRANSCRIPT LEVELS IN CHRONIC MYELOID LEUKEMIA PATIENTS: PCR-DEPTH STUDY
- Authors
- Lee, W-S.; Kim, H-J.; Kong, J. H.; Kim, H.; Do, Y. R.; Kwak, J-Y.; Oh, S.; Kim, S. H.; Kim, J-A.; Zang, D. Y.; Mun, Y-C.; Won, Y-W.; Lee, S-E.; Choi, S-Y.; Kim, S-H.; Choi, M-Y.; Kim, D-W.
- Ewha Authors
- 문영철
- SCOPUS Author ID
- 문영철
- Issue Date
- 2017
- Journal Title
- HAEMATOLOGICA
- ISSN
- 0390-6078
- Citation
- HAEMATOLOGICA vol. 102, pp. 434 - 434
- Publisher
- FERRATA STORTI FOUNDATION
- Indexed
- SCIE; SCOPUS
- Document Type
- Meeting Abstract
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML